These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 10677730)
61. Cytokine production in hearts of Trypanosoma cruzi-infected CBA mice: Do cytokine patterns in chronic stage reflect the establishment of myocardial pathology? Sunnemark D; Ulfgren AK; Orn A; Harris RA Scand J Immunol; 1996 Nov; 44(5):421-9. PubMed ID: 8947592 [TBL] [Abstract][Full Text] [Related]
62. Trypanosoma cruzi: infectivity and virulence of trypomastigotes incubated with leukocytes and serum from patients with Chagas' disease. Mosca W; Briceño L; Velasco J Acta Cient Venez; 1992; 43(5):290-4. PubMed ID: 1343741 [TBL] [Abstract][Full Text] [Related]
63. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807 [TBL] [Abstract][Full Text] [Related]
64. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Soares MB; Lima RS; Souza BS; Vasconcelos JF; Rocha LL; Dos Santos RR; Iacobas S; Goldenberg RC; Lisanti MP; Iacobas DA; Tanowitz HB; Spray DC; Campos de Carvalho AC Cell Cycle; 2011 May; 10(9):1448-55. PubMed ID: 21467843 [TBL] [Abstract][Full Text] [Related]
65. Pathogenesis of Chagas heart disease: role of autoimmunity. Engman DM; Leon JS Acta Trop; 2002 Feb; 81(2):123-32. PubMed ID: 11801219 [TBL] [Abstract][Full Text] [Related]
66. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Abel LC; Kalil J; Cunha Neto E Braz J Med Biol Res; 1997 Nov; 30(11):1305-8. PubMed ID: 9532238 [TBL] [Abstract][Full Text] [Related]
67. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Hernández-Becerril N; Nava A; Reyes PA; Monteón VM Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655 [TBL] [Abstract][Full Text] [Related]
68. Detection of T. cruzi antigens reactive with IgG antibodies from patients with chronic Chagas' disease. Gea S; Evequoz C; Rodríguez P; Vottero-Cima E Medicina (B Aires); 1986; 46(2):163-6. PubMed ID: 3553838 [No Abstract] [Full Text] [Related]
69. Presence of antiheart and antiskeletal muscle glycolipid autoantibodies in the sera of patients with chagasic cardiopathy. Laguens RP; Argel MI; Chambó J; Storino R; Cabeza Meckert PM Can J Cardiol; 1994 Sep; 10(7):769-76. PubMed ID: 7922834 [TBL] [Abstract][Full Text] [Related]
70. Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy. Pérez-Mazliah DE; Castro Eiro MD; Álvarez MG; Lococo B; Bertocchi G; César G; Natale MA; Albareda MC; Viotti R; Laucella SA PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006887. PubMed ID: 30346948 [TBL] [Abstract][Full Text] [Related]
71. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. Pontes-de-Carvalho L; Santana CC; Soares MB; Oliveira GG; Cunha-Neto E; Ribeiro-dos-Santos R J Autoimmun; 2002 Mar; 18(2):131-8. PubMed ID: 11908945 [TBL] [Abstract][Full Text] [Related]
72. Characterization of the cellular immune response in Chagas' disease patients. Castes M; Araujo Z; Mosca W Acta Cient Venez; 1986; 37(5):547-53. PubMed ID: 3129894 [No Abstract] [Full Text] [Related]
73. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease. Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859 [TBL] [Abstract][Full Text] [Related]
75. Is apoptosis a mechanism of cell death of cardiomyocytes in chronic chagasic myocarditis? Rossi MA; Souza AC Int J Cardiol; 1999 Mar; 68(3):325-31. PubMed ID: 10213285 [TBL] [Abstract][Full Text] [Related]
76. Immunopathology of cardiomyopathy in the experimental Chagas disease. Soares MB; Santos RR Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():257-62. PubMed ID: 10677729 [TBL] [Abstract][Full Text] [Related]
77. Autoimmunity in Chagas' heart disease. Cunha-Neto E; Kalil J Sao Paulo Med J; 1995; 113(2):757-66. PubMed ID: 8650474 [TBL] [Abstract][Full Text] [Related]
78. [Trypanosoma cruzi and chronic Chagas heart disease]. Bellotti G; Pileggi F Arq Bras Cardiol; 1993 Oct; 61(4):203-5. PubMed ID: 8154997 [No Abstract] [Full Text] [Related]
79. 5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection. Pavanelli WR; Gutierrez FR; Mariano FS; Prado CM; Ferreira BR; Teixeira MM; Canetti C; Rossi MA; Cunha FQ; Silva JS Microbes Infect; 2010 Aug; 12(8-9):587-97. PubMed ID: 20381637 [TBL] [Abstract][Full Text] [Related]
80. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease. Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]